BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Feilim Maxwell
Current InstitutionGlaxoSmithKline plc
Current DepartmentSlough
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
02/A4/D/08644 Optimising the nutritional value of Horlicks Co-Supervisor 41,786 Studentships
terms and conditions of use (opens in new window)
export PDF file